Publications by authors named "Sarah Zheng"

The surge of online scams is taking a considerable financial and emotional toll. This is partially because humans are poor at detecting lies. In a series of three online experiments (N = 102, N = 108, N = 100) where participants are given the opportunity to lie as well as to assess the potential lies of others, we show that poor lie detection is related to the suboptimal computations people engage in when assessing lies.

View Article and Find Full Text PDF

Misinformation can negatively impact people's lives in domains ranging from health to politics. An important research goal is to understand how misinformation spreads in order to curb it. Here, we test whether and how a single repetition of misinformation fuels its spread.

View Article and Find Full Text PDF

Background: The few studies that have examined the relationship between midlife cardiovascular disease risk and longer-term costs have differentiated risk using a small number of risk categories. In this paper, we illustrate the advantages of a continuous-valued score to examine the relationship between risk and longer-term costs: the Framingham 10-year coronary heart disease risk score.

Methods: Our study cohort consisted of 1333 Second Generation Framingham Heart Study participants enrolled in fee-for-service Medicare for at least 8 quarters and who had a risk score assessment between age 40 and 50 years.

View Article and Find Full Text PDF

Background: To overcome the limitations of administrative data in adequately adjusting for differences in patients' risk of readmissions, recent studies have added supplemental data from patient surveys and other sources (e.g., electronic health records).

View Article and Find Full Text PDF

Importance: High-risk medical devices often undergo modifications, which are approved by the US Food and Drug Administration (FDA) through various kinds of premarket approval (PMA) supplements. There have been multiple high-profile recalls of devices approved as PMA supplements.

Objective: To characterize the quality of the clinical studies and data (strength of evidence) used to support FDA approval of panel-track supplements (a type of PMA supplement pathway that is used for significant changes in a device or indication for use and always requires clinical data).

View Article and Find Full Text PDF

Background: Diagnostic imaging utilization grew rapidly over the past 2 decades. It remains unclear whether patient cost-sharing is an effective policy lever to reduce imaging utilization and spending.

Materials And Methods: Using 2010 commercial insurance claims data of >21 million individuals, we compared diagnostic imaging utilization and standardized payments between High Deductible Health Plan (HDHP) and non-HDHP enrollees.

View Article and Find Full Text PDF

The case of a patient with recurrent esthesioneuroblastoma complicated by ectopic adrenocorticotropic hormone production is presented, including the workup and management of this uncommon complication of an uncommon disease.

View Article and Find Full Text PDF